Farideh Z Bischoff
Overview
Explore the profile of Farideh Z Bischoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
987
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paoletti C, Cani A, Larios J, Hovelson D, Aung K, Darga E, et al.
Cancer Res
. 2017 Dec;
78(4):1110-1122.
PMID: 29233927
Addressing drug resistance is a core challenge in cancer research, but the degree of heterogeneity in resistance mechanisms in cancer is unclear. In this study, we conducted next-generation sequencing (NGS)...
2.
Pradeep S, Kim S, Wu S, Nishimura M, Chaluvally-Raghavan P, Miyake T, et al.
Cancer Cell
. 2014 Jul;
26(1):77-91.
PMID: 25026212
Ovarian cancer has a clear predilection for metastasis to the omentum, but the underlying mechanisms involved in ovarian cancer spread are not well understood. Here, we used a parabiosis model...
3.
Dickson M, Tsinberg P, Tang Z, Bischoff F, Wilson T, Leonard E
Biomicrofluidics
. 2012 Jun;
5(3):34119-3411915.
PMID: 22662044
Ability to perform cytogenetic interrogations on circulating tumor cells (CTCs) from the blood of cancer patients is vital for progressing toward targeted, individualized treatments. CTCs are rare compared to normal...
4.
Mayer J, Pham T, Wong K, Scoggin J, Sales E, Clarin T, et al.
Cancer Genet
. 2011 Dec;
204(11):589-95.
PMID: 22200084
Determination of HER2 status in breast cancer patients is considered standard practice for therapy selection. However, tumor biopsy in patients with recurrent and/or metastatic disease is not always feasible. Thus,...
5.
Pecot C, Bischoff F, Mayer J, Wong K, Pham T, Bottsford-Miller J, et al.
Cancer Discov
. 2011 Dec;
1(7):580-6.
PMID: 22180853
Unlabelled: Metastasis is a complex, multistep process that begins with the epithelial-mesenchymal transition (EMT). Circulating tumor cells (CTC) are believed to have undergone EMT and thus lack or express low...
6.
Mikolajczyk S, Millar L, Tsinberg P, Coutts S, Zomorrodi M, Pham T, et al.
J Oncol
. 2011 May;
2011:252361.
PMID: 21577258
Enrichment of rare circulating tumor cells (CTCs) in blood is typically achieved using antibodies to epithelial cell adhesion molecule (EpCAM), with detection using cytokeratin (CK) antibodies. However, EpCAM and CK...
7.
Kamat A, Baldwin M, Urbauer D, Dang D, Han L, Godwin A, et al.
Cancer
. 2010 Feb;
116(8):1918-25.
PMID: 20166213
Background: Cell-free DNA reflects both normal and tumor-derived DNA released into the circulation through cellular necrosis and apoptosis. The authors sought to determine the role of preoperative total plasma cell-free...
8.
Jorgez C, Bischoff F
Fetal Diagn Ther
. 2009 Sep;
25(3):314-9.
PMID: 19776594
Objective: Among the pitfalls of using cell-free fetal DNA in plasma for prenatal diagnosis is quality of the recovered DNA fragments and concomitant presence of maternal DNA (>95%). Our objective...
9.
Jorgez C, Bischoff F
Reprod Biomed Online
. 2008 Nov;
17(5):716-21.
PMID: 18983758
Having demonstrated successful recovery and detection of placental transcripts from dried blood spots (DBS), various preanalytical conditions were examined to determine optimal handling of samples. The role of several factors...
10.
Orozco A, Jorgez C, Horne C, Marquez-Do D, Chapman M, Rodgers J, et al.
Am J Pathol
. 2008 Nov;
173(6):1595-608.
PMID: 18974299
Microparticles (MPs) that circulate in blood may be a source of DNA for molecular analyses, including prenatal genetic diagnoses. Because MPs are heterogeneous in nature, however, further characterization is important...